Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality

Archives of Dermatology

Volumn 145, Issue 6, 2009, Pages 700-703

  Prodanovich, Srjdan ^a   Kirsner, Robert S ^a,b   Kravetz, Jeffrey D ^c,d   Ma, Fangchao ^e   Martinez, Lisa ^a   Federman, Daniel G ^c,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Departments of Medicine   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ILLINOIS DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PSORIASIS; RISK ASSESSMENT; RISK FACTOR; SMOKING;

AGE DISTRIBUTION; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; COMORBIDITY; CONFIDENCE INTERVALS; CORONARY DISEASE; FEMALE; HOSPITALS, VETERANS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PROBABILITY; PROGNOSIS; PSORIASIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 67449110958     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.94     Document Type: Article

References (27)

1. Psoriasis statistics. National Psoriasis Foundation Web site. www.psoriasis.org/about/stats. Accessed June 16, 2008.
2. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3, pt 1):401-407. (Pubitemid 29418506)
3. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280-284.
4. Leary MR, Rapp SR, Herbst KC, Exum ML, Feldman SR. Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation. Health Psychol. 1998;17(6):530-536. (Pubitemid 28541535)
5. Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005;352(18):1899- 1912.
6. Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003;30(1):36-40. (Pubitemid 36077769)
7. Rhew EY, Ramsey-Goldman R. Premature atherosclerotic disease in systemic lupus erythematosus - role of inflammatory mechanisms. Autoimmun Rev. 2006;5(2):101-105. (Pubitemid 43129536)
8. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol. 2007;57(2):347-354. (Pubitemid 47048862)
9. Shapiro J, Cohen AD, David M, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol. 2007;56(4):629-634. (Pubitemid 46400186)
10. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32(6):982-986.
11. Mallbris L, Granath F, Hamsten A, Stahle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54(4):614-621.
12. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta. 2001;303(1-2):33-39. (Pubitemid 32121803)
13. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichental M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298(7):321-328. (Pubitemid 44777680)
14. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-835. (Pubitemid 44556851)
15. Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med. 2007;120(11):953-959. (Pubitemid 350011082)
16. Fortes C, Mastroeni S, Leffondré K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol. 2005;141(12):1580-1584. (Pubitemid 41815850)
17. Huerta C, Rivero E, Rodríguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007;143(12):1559-1565. (Pubitemid 350277774)
18. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735-1741. (Pubitemid 44547793)
19. Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. 2007;143(12):1493-1499. (Pubitemid 350277763)
20. Rosamond W, Flegal K, Furie K, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommitee. Circulation. 2008;117(4):e25-e146.
21. Rockson SG, Cooke JP. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. Adv Intern Med. 1998;43:253-277.
22. Justice AC, Lasky E, McGinnis KA, et al; VACS 3 Project Team. Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies. Med Care. 2006;44(8)(suppl 2):S52-S60.
23. Boyman O, Conrad C, Tonel G, Gilliet M, Nestle FO. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol. 2007;28(2):51-57. (Pubitemid 46176734)
24. Federman DG, Kravetz JD. Peripheral arterial disease: diagnosis, treatment, and systemic implications. Clin Dermatol. 2007;25(1):93-100. (Pubitemid 46177459)
25. Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol. 2005;52(2):262-267.
26. Kimball AB, Gladman D, Gelfand JM, et al; National Psoriasis Foundation. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008;58(6):1031-1042.
27. Ludwig RJ, Herzog C, Rostock A, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol. 2007;156(2):271-276. (Pubitemid 46095954)